OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $70,250 | -92.5% | 25,000 | -44.4% | 0.00% | -95.2% |
Q4 2020 | $933,000 | +276.2% | 45,000 | -10.0% | 0.02% | +50.0% |
Q1 2020 | $248,000 | +90.8% | 50,000 | +52.4% | 0.01% | +250.0% |
Q4 2019 | $130,000 | -12.2% | 32,800 | -32.2% | 0.00% | -42.9% |
Q3 2019 | $148,000 | – | 48,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |